CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS

This adverse event was reported 6 times

These drugs are most commonly taken by patients reporting CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS:

# Drug Count
0 ATOVAQUONE 4
1 ATOVAQUONE ORAL SUSPENSION 4
2 QUININE 4
3 CLINDAMYCIN 3
4 CLINDAMYCIN PHOSPHATE 3
5 LENALIDOMIDE 2
6 QUININE SULFATE 2
7 BORTEZOMIB 1
8 CARFILZOMIB 1
9 CLINDAMYCIN PALMITATE HYDROCHLORIDE 1
See all common drugs associated with CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS

CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLINDAMYCIN PALMITATE HYDROCHLORIDE 1 0.0044
1 CLINDAMYCIN PHOSPHATE 3 0.0005
2 ATOVAQUONE 4 0.0005
3 QUININE 4 0.0005
4 MELPHALAN HYDROCHLORIDE 1 0.0000
5 CARFILZOMIB 1 0.0000
6 BORTEZOMIB 1 0.0000
7 POMALIDOMIDE 1 0.0000
8 LENALIDOMIDE 2 0.0000
9 DEXAMETHASONE 1.5 MG 1 0.0000
See all drugs enriched for association with CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS

These drug classes are most commonly taken by patients reporting CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS:

# Drug class Count
0 Antimalarial [EPC] 4
1 Antiprotozoal [EPC] 4
2 Thalidomide Analog [EPC] 2
3 CD38-directed Cytolytic Antibody [EPC] 1
4 Corticosteroid [EPC] 1
5 Proteasome Inhibitor [EPC] 1
See all common drug classes associated with CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS

CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimalarial [EPC] 4 0.0004
1 Antiprotozoal [EPC] 4 0.0004
2 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
3 Proteasome Inhibitor [EPC] 1 0.0000
4 Thalidomide Analog [EPC] 2 0.0000
5 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS